MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/jcrt.jcrt_2346_21

Медицинская библиотека · Journal of cancer research and therapeutics · 2023

Safety and efficacy of oral pilocarpine in radiation-induced xerostomia in oropharyngeal carcinoma patients.

Kaur Harkirat, Singh Banipal Raja Paramjeet, Singh Harminder, Sonik Yasmeen Atwal, Sandhu Snehpreet Kaur

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

CONTEXT: Patients with head-and-neck cancers can develop salivary gland hypofunction after radiotherapy. Oral pilocarpine has been shown to be effective treatment for radiation-induced xerostomia, although its usefulness is being discussed.

AIMS: We aimed to evaluate the efficacy and safety profile of oral pilocarpine in radiation-induced xerostomia.

MATERIALS AND

METHODS

Sixty patients with oropharyngeal carcinoma were planned for radiotherapy and divided into two arms randomly: Arm A (30 patients) received oral pilocarpine and Arm B (30 patients) received placebo tablets for 12 weeks after 3 months of completion of radiotherapy. Salivary gland scintigraphy and xerostomia questionnaire (XQ) were obtained from each patient at baseline and at 3 and 6 months of completion of radiotherapy.

RESULTS

There was a marked decrease in uptake ratio (UR) and excretion fraction (EF) after 3 months of completion of radiotherapy. There was a statistically significant difference between both the arms in relation to UR, but no significant difference was observed between the two arms in relation to EF after 6 months of completion of radiotherapy. A statistically significant difference was found comparing the XQ results in both the arms. The XQ results did not correlate with salivary gland dysfunction observed by means of salivary scintigraphy. Adverse effects due to xerostomia were generally mild and occasionally of moderate severity.

CONCLUSION

The use of oral pilocarpine did not significantly improve salivary gland excretory function, despite better results on salivary uptake at 6 months. However, oral pilocarpine significantly improved symptoms of xerostomia with minor side effects that were predominantly limited to sweating.

Для цитирования: Kaur Harkirat, Singh Banipal Raja Paramjeet, Singh Harminder, Sonik Yasmeen Atwal, Sandhu Snehpreet Kaur. Safety and efficacy of oral pilocarpine in radiation-induced xerostomia in oropharyngeal carcinoma patients.. Journal of cancer research and therapeutics. 2023. DOI: 10.4103/jcrt.jcrt_2346_21.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.